retatrutide clinical trials phase 3 New GLP-3 drug significantly slashes both weight and blood sugar levels in III trial Retatrutide phase 3 obesity trial

Retatrutide doses continue escalating, producing progressively stronger metabolic effects

While kojic acid isn't technically an exfoliant like AHA or BHA, it does help promote cell turnover, which means fresher, brighter skin surfaces more quickly

Whether practicing as a physician, nurse practitioner, physician associate, or registered dietitian, healthcare professionals need evidence-based, practical strategies to safely optimize GLP-1 therapy

Feeling ready to take the next step in your weight management journey

Effect of betaine on reducing body fata systematic review and meta-analysis of randomized controlled trials

Safety, side effects, and clinical oversight The FDA-labeled side-effect profile for GLP-1 receptor agonists and the GIP/GLP-1 dual agonist tirzepatide is well-characterized: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common